arrow_back Back to App

Ban on Federal Funding for Research Using Aborted Human Fetal Tissue

This Act imposes a complete prohibition on U.S. federal agencies (such as the NIH) from conducting, funding, or supporting research that uses human fetal tissue obtained from induced abortions. This means that government-funded medical research and development must rely solely on tissue obtained from miscarriages or stillbirths. For citizens, this legislation may shift the focus and pace of certain medical research, including work on new vaccines and gene therapies, by mandating the use of alternative, ethical cell sources.
Key points
Total Prohibition: No federal agency may conduct or fund research involving human fetal tissue obtained pursuant to an induced abortion.
Permitted Research: Research using human fetal tissue obtained after a miscarriage or stillbirth remains permitted and regulated.
New Cell Lines: The development of new, high-efficiency cell lines (e.g., for vaccine production) is allowed, provided they are not derived from tissue obtained from induced abortions.
Acquisition Ban: The knowing acquisition, receipt, or acceptance of a donation of human fetal tissue is prohibited if it is known that the tissue was obtained pursuant to an induced abortion.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_3713
Sponsor: Sen. Hyde-Smith, Cindy [R-MS]
Process start date: 2024-01-31